Ukraine

Ukraine

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.3 (1.14 - 1.47) 2019 Modelled IHME
1.32 (1.17 - 1.48) 2018 Modelled IHME
1.36 (1.19 - 1.51) 2017 Modelled IHME
1.4 (1.24 - 1.56) 2016 Modelled IHME
1.44 (1.28 - 1.61) 2015 Modelled IHME
1.49 (1.32 - 1.65) 2014 Modelled IHME
1.53 (1.36 - 1.69) 2013 Modelled IHME
1.58 (1.40 - 1.74) 2012 Modelled IHME
1.62 (1.43 - 1.79) 2011 Modelled IHME
1.65 (1.46 - 1.83) 2010 Modelled IHME
1.68 (1.48 - 1.86) 2009 Modelled IHME
1.7 (1.51 - 1.88) 2008 Modelled IHME
1.73 (1.53 - 1.90) 2007 Modelled IHME
1.75 (1.53 - 1.93) 2006 Modelled IHME
1.76 (1.54 - 1.95) 2005 Modelled IHME
1.76 (1.55 - 1.95) 2004 Modelled IHME
1.76 (1.55 - 1.96) 2003 Modelled IHME
1.76 (1.56 - 1.96) 2002 Modelled IHME
1.76 (1.55 - 1.97) 2001 Modelled IHME
1.76 (1.55 - 1.97) 2000 Modelled IHME
1.76 (1.55 - 1.96) 1999 Modelled IHME
1.74 (1.53 - 1.94) 1998 Modelled IHME
1.71 (1.51 - 1.91) 1997 Modelled IHME
1.69 (1.49 - 1.89) 1996 Modelled IHME
1.68 (1.48 - 1.88) 1995 Modelled IHME
1.68 (1.47 - 1.88) 1994 Modelled IHME
1.68 (1.47 - 1.88) 1993 Modelled IHME
1.67 (1.47 - 1.89) 1992 Modelled IHME
1.67 (1.46 - 1.90) 1991 Modelled IHME
1.68 (1.45 - 1.92) 1990 Modelled IHME
1.14 (0.76 - 1.68) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.29 (0.23 - 0.35) 2019 Modelled IHME
0.3 (0.25 - 0.36) 2018 Modelled IHME
0.33 (0.27 - 0.41) 2017 Modelled IHME
0.68 (0.56 - 0.81) 2016 Modelled IHME
1 (0.81 - 1.22) 2015 Modelled IHME
0.98 (0.79 - 1.17) 2014 Modelled IHME
0.9 (0.74 - 1.08) 2013 Modelled IHME
0.81 (0.65 - 0.96) 2012 Modelled IHME
0.71 (0.57 - 0.84) 2011 Modelled IHME
0.62 (0.50 - 0.74) 2010 Modelled IHME
0.54 (0.43 - 0.64) 2009 Modelled IHME
0.44 (0.36 - 0.53) 2008 Modelled IHME
0.36 (0.29 - 0.43) 2007 Modelled IHME
0.3 (0.24 - 0.36) 2006 Modelled IHME
0.27 (0.22 - 0.33) 2005 Modelled IHME
0.4 (0.33 - 0.48) 2004 Modelled IHME
0.71 (0.58 - 0.84) 2003 Modelled IHME
1.07 (0.88 - 1.28) 2002 Modelled IHME
1.38 (1.13 - 1.66) 2001 Modelled IHME
1.51 (1.23 - 1.83) 2000 Modelled IHME
1.51 (1.24 - 1.82) 1999 Modelled IHME
1.51 (1.25 - 1.80) 1998 Modelled IHME
1.51 (1.25 - 1.78) 1997 Modelled IHME
1.51 (1.24 - 1.77) 1996 Modelled IHME
1.51 (1.24 - 1.77) 1995 Modelled IHME
1.51 (1.25 - 1.76) 1994 Modelled IHME
1.51 (1.25 - 1.76) 1993 Modelled IHME
1.51 (1.25 - 1.78) 1992 Modelled IHME
1.51 (1.23 - 1.79) 1991 Modelled IHME
1.52 (1.21 - 1.82) 1990 Modelled IHME
0.46 (0.30 - 0.72) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.63 (6.74 - 10.80) 2019 Modelled IHME
8.2 (6.54 - 10.10) 2018 Modelled IHME
7.88 (6.51 - 9.42) 2017 Modelled IHME
7.76 (6.61 - 9.08) 2016 Modelled IHME
7.95 (6.78 - 9.33) 2015 Modelled IHME
6.61 (5.65 - 7.69) 2014 Modelled IHME
8.02 (6.85 - 9.35) 2013 Modelled IHME
9.13 (7.82 - 10.60) 2012 Modelled IHME
9.94 (8.58 - 11.50) 2011 Modelled IHME
10.9 (9.31 - 12.60) 2010 Modelled IHME
11.8 (10.10 - 13.70) 2009 Modelled IHME
13.9 (11.90 - 16.10) 2008 Modelled IHME
13.4 (11.50 - 15.70) 2007 Modelled IHME
12.2 (10.40 - 14.20) 2006 Modelled IHME
12.1 (10.30 - 14.10) 2005 Modelled IHME
10.9 (9.30 - 12.60) 2004 Modelled IHME
9.55 (8.21 - 11) 2003 Modelled IHME
8.73 (7.49 - 10.10) 2002 Modelled IHME
7.83 (6.70 - 9.02) 2001 Modelled IHME
7.33 (6.28 - 8.42) 2000 Modelled IHME
6.54 (5.61 - 7.52) 1999 Modelled IHME
5.97 (5.14 - 6.89) 1998 Modelled IHME
6.19 (5.34 - 7.14) 1997 Modelled IHME
6.27 (5.42 - 7.27) 1996 Modelled IHME
6.14 (5.29 - 7.19) 1995 Modelled IHME
5.35 (4.64 - 6.23) 1994 Modelled IHME
4.88 (4.24 - 5.69) 1993 Modelled IHME
4.51 (3.91 - 5.26) 1992 Modelled IHME
4.12 (3.56 - 4.82) 1991 Modelled IHME
3.73 (3.23 - 4.36) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,799 (2,968 - 4,764) 2019 Modelled IHME
3,641 (2,901 - 4,462) 2018 Modelled IHME
3,521 (2,908 - 4,210) 2017 Modelled IHME
3,493 (2,974 - 4,085) 2016 Modelled IHME
3,600 (3,070 - 4,226) 2015 Modelled IHME
3,008 (2,572 - 3,503) 2014 Modelled IHME
3,665 (3,130 - 4,276) 2013 Modelled IHME
4,190 (3,590 - 4,878) 2012 Modelled IHME
4,582 (3,954 - 5,316) 2011 Modelled IHME
5,033 (4,308 - 5,830) 2010 Modelled IHME
5,496 (4,716 - 6,371) 2009 Modelled IHME
6,482 (5,545 - 7,546) 2008 Modelled IHME
6,329 (5,412 - 7,378) 2007 Modelled IHME
5,779 (4,951 - 6,727) 2006 Modelled IHME
5,767 (4,912 - 6,743) 2005 Modelled IHME
5,247 (4,480 - 6,086) 2004 Modelled IHME
4,635 (3,984 - 5,359) 2003 Modelled IHME
4,271 (3,663 - 4,928) 2002 Modelled IHME
3,861 (3,305 - 4,445) 2001 Modelled IHME
3,642 (3,118 - 4,183) 2000 Modelled IHME
3,271 (2,805 - 3,761) 1999 Modelled IHME
3,006 (2,589 - 3,470) 1998 Modelled IHME
3,140 (2,709 - 3,624) 1997 Modelled IHME
3,204 (2,769 - 3,718) 1996 Modelled IHME
3,166 (2,724 - 3,702) 1995 Modelled IHME
2,774 (2,409 - 3,231) 1994 Modelled IHME
2,548 (2,213 - 2,968) 1993 Modelled IHME
2,365 (2,048 - 2,758) 1992 Modelled IHME
2,164 (1,873 - 2,532) 1991 Modelled IHME
1,963 (1,703 - 2,294) 1990 Modelled IHME
4,746 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
23 (20 - 27) 2019 Modelled IHME
23 (19 - 27) 2018 Modelled IHME
23 (19 - 27) 2017 Modelled IHME
23 (20 - 27) 2016 Modelled IHME
23 (20 - 27) 2015 Modelled IHME
22 (19 - 26) 2014 Modelled IHME
23 (20 - 27) 2013 Modelled IHME
24 (21 - 28) 2012 Modelled IHME
24 (21 - 28) 2011 Modelled IHME
25 (21 - 29) 2010 Modelled IHME
25 (22 - 29) 2009 Modelled IHME
25 (22 - 30) 2008 Modelled IHME
25 (22 - 29) 2007 Modelled IHME
25 (21 - 29) 2006 Modelled IHME
25 (21 - 29) 2005 Modelled IHME
24 (20 - 28) 2004 Modelled IHME
23 (20 - 27) 2003 Modelled IHME
23 (20 - 27) 2002 Modelled IHME
23 (20 - 27) 2001 Modelled IHME
23 (20 - 27) 2000 Modelled IHME
23 (20 - 27) 1999 Modelled IHME
23 (20 - 27) 1998 Modelled IHME
23 (20 - 27) 1997 Modelled IHME
23 (20 - 28) 1996 Modelled IHME
24 (20 - 28) 1995 Modelled IHME
23 (20 - 27) 1994 Modelled IHME
23 (20 - 27) 1993 Modelled IHME
23 (20 - 27) 1992 Modelled IHME
23 (20 - 27) 1991 Modelled IHME
23 (20 - 27) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
49 2018 Survey/reported WHO/UNICEF
49 2017 Survey/reported WHO/UNICEF
37 2016 Survey/reported WHO/UNICEF
57 2015 Survey/reported WHO/UNICEF
57 2014 Survey/reported WHO/UNICEF
51 2013 Survey/reported WHO/UNICEF
51 2012 Survey/reported WHO/UNICEF
53 2011 Survey/reported WHO/UNICEF
64 2010 Survey/reported WHO/UNICEF
73 2009 Survey/reported WHO/UNICEF
82 2008 Survey/reported WHO/UNICEF
89 2007 Survey/reported WHO/UNICEF
88 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
85 2003 Survey/reported WHO/UNICEF
70 2002 Survey/reported WHO/UNICEF
34 2001 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
52 2018 Survey/reported WHO/UNICEF
52 2017 Survey/reported WHO/UNICEF
26 2016 Survey/reported WHO/UNICEF
22 2015 Survey/reported WHO/UNICEF
22 2014 Survey/reported WHO/UNICEF
46 2013 Survey/reported WHO/UNICEF
46 2012 Survey/reported WHO/UNICEF
21 2011 Survey/reported WHO/UNICEF
48 2010 Survey/reported WHO/UNICEF
66 2009 Survey/reported WHO/UNICEF
84 2008 Survey/reported WHO/UNICEF
92 2007 Survey/reported WHO/UNICEF
96 2006 Survey/reported WHO/UNICEF
97 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
77 2003 Survey/reported WHO/UNICEF
48 2002 Survey/reported WHO/UNICEF
7 2001 Survey/reported WHO/UNICEF
4 2000 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
61 (33 - 113) 2015 Survey/reported Alliance for Publi Health, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
5 (4.60 - 5.50) 2015 Survey/reported Barska G and Sazanov JA, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2002
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.7 (2.18 - 3.34) 2019 Modelled IHME
2.72 (2.19 - 3.36) 2018 Modelled IHME
2.72 (2.20 - 3.38) 2017 Modelled IHME
2.68 (2.17 - 3.29) 2016 Modelled IHME
2.64 (2.12 - 3.24) 2015 Modelled IHME
2.63 (2.12 - 3.22) 2014 Modelled IHME
2.62 (2.12 - 3.22) 2013 Modelled IHME
2.61 (2.11 - 3.22) 2012 Modelled IHME
2.61 (2.11 - 3.22) 2011 Modelled IHME
2.6 (2.10 - 3.22) 2010 Modelled IHME
2.58 (2.08 - 3.21) 2009 Modelled IHME
2.56 (2.06 - 3.18) 2008 Modelled IHME
2.53 (2.03 - 3.15) 2007 Modelled IHME
2.5 (2.01 - 3.11) 2006 Modelled IHME
2.47 (1.98 - 3.08) 2005 Modelled IHME
2.45 (1.97 - 3.04) 2004 Modelled IHME
2.42 (1.95 - 2.99) 2003 Modelled IHME
2.39 (1.92 - 2.96) 2002 Modelled IHME
2.36 (1.90 - 2.91) 2001 Modelled IHME
2.32 (1.88 - 2.87) 2000 Modelled IHME
2.28 (1.83 - 2.80) 1999 Modelled IHME
2.22 (1.80 - 2.73) 1998 Modelled IHME
2.16 (1.75 - 2.67) 1997 Modelled IHME
2.11 (1.70 - 2.61) 1996 Modelled IHME
2.07 (1.66 - 2.57) 1995 Modelled IHME
2.04 (1.64 - 2.54) 1994 Modelled IHME
2.01 (1.62 - 2.50) 1993 Modelled IHME
1.99 (1.60 - 2.47) 1992 Modelled IHME
1.98 (1.58 - 2.46) 1991 Modelled IHME
1.97 (1.57 - 2.44) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
3.6 (0.90 - 4.50) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
53.9 (49.20 - 58.70) 2015 Modelled Degenhardt L et al, 2017

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.76 (7.76 - 12.10) 2019 Modelled IHME
9.91 (8.06 - 12.10) 2018 Modelled IHME
10 (8.30 - 11.80) 2017 Modelled IHME
10.3 (8.84 - 11.80) 2016 Modelled IHME
10.7 (9.17 - 12.40) 2015 Modelled IHME
8.21 (7.13 - 9.52) 2014 Modelled IHME
8.49 (7.36 - 9.83) 2013 Modelled IHME
8.16 (7.08 - 9.49) 2012 Modelled IHME
7.86 (6.78 - 9.14) 2011 Modelled IHME
8.16 (7.08 - 9.47) 2010 Modelled IHME
8.83 (7.61 - 10.20) 2009 Modelled IHME
10.3 (8.86 - 11.90) 2008 Modelled IHME
10 (8.64 - 11.70) 2007 Modelled IHME
9.16 (7.89 - 10.60) 2006 Modelled IHME
9.08 (7.82 - 10.60) 2005 Modelled IHME
8.21 (7.08 - 9.55) 2004 Modelled IHME
7.2 (6.22 - 8.39) 2003 Modelled IHME
6.57 (5.68 - 7.63) 2002 Modelled IHME
5.89 (5.10 - 6.83) 2001 Modelled IHME
5.51 (4.76 - 6.39) 2000 Modelled IHME
4.94 (4.28 - 5.70) 1999 Modelled IHME
4.53 (3.90 - 5.22) 1998 Modelled IHME
4.69 (4.07 - 5.42) 1997 Modelled IHME
4.75 (4.11 - 5.50) 1996 Modelled IHME
4.66 (4.02 - 5.42) 1995 Modelled IHME
4.08 (3.52 - 4.72) 1994 Modelled IHME
3.73 (3.23 - 4.32) 1993 Modelled IHME
3.45 (2.99 - 4) 1992 Modelled IHME
3.15 (2.74 - 3.67) 1991 Modelled IHME
2.86 (2.49 - 3.33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4,298 (3,416 - 5,344) 2019 Modelled IHME
4,397 (3,575 - 5,351) 2018 Modelled IHME
4,468 (3,710 - 5,275) 2017 Modelled IHME
4,616 (3,977 - 5,331) 2016 Modelled IHME
4,843 (4,155 - 5,624) 2015 Modelled IHME
3,736 (3,246 - 4,333) 2014 Modelled IHME
3,879 (3,367 - 4,495) 2013 Modelled IHME
3,744 (3,249 - 4,355) 2012 Modelled IHME
3,620 (3,125 - 4,212) 2011 Modelled IHME
3,777 (3,275 - 4,383) 2010 Modelled IHME
4,104 (3,536 - 4,751) 2009 Modelled IHME
4,818 (4,141 - 5,586) 2008 Modelled IHME
4,726 (4,069 - 5,494) 2007 Modelled IHME
4,342 (3,741 - 5,039) 2006 Modelled IHME
4,338 (3,736 - 5,052) 2005 Modelled IHME
3,955 (3,411 - 4,601) 2004 Modelled IHME
3,496 (3,019 - 4,071) 2003 Modelled IHME
3,215 (2,777 - 3,732) 2002 Modelled IHME
2,905 (2,515 - 3,367) 2001 Modelled IHME
2,739 (2,362 - 3,173) 2000 Modelled IHME
2,470 (2,139 - 2,853) 1999 Modelled IHME
2,281 (1,967 - 2,631) 1998 Modelled IHME
2,381 (2,063 - 2,750) 1997 Modelled IHME
2,429 (2,101 - 2,812) 1996 Modelled IHME
2,403 (2,069 - 2,792) 1995 Modelled IHME
2,115 (1,825 - 2,452) 1994 Modelled IHME
1,949 (1,688 - 2,253) 1993 Modelled IHME
1,811 (1,567 - 2,099) 1992 Modelled IHME
1,658 (1,441 - 1,929) 1991 Modelled IHME
1,505 (1,310 - 1,754) 1990 Modelled IHME
3,186 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
29 (25 - 33) 2019 Modelled IHME
29 (25 - 33) 2018 Modelled IHME
29 (25 - 33) 2017 Modelled IHME
29 (26 - 33) 2016 Modelled IHME
29 (25 - 32) 2015 Modelled IHME
30 (26 - 33) 2014 Modelled IHME
29 (26 - 33) 2013 Modelled IHME
29 (25 - 32) 2012 Modelled IHME
28 (25 - 32) 2011 Modelled IHME
28 (24 - 32) 2010 Modelled IHME
28 (24 - 31) 2009 Modelled IHME
27 (24 - 31) 2008 Modelled IHME
28 (24 - 31) 2007 Modelled IHME
28 (25 - 32) 2006 Modelled IHME
28 (25 - 32) 2005 Modelled IHME
29 (26 - 33) 2004 Modelled IHME
30 (26 - 34) 2003 Modelled IHME
30 (27 - 34) 2002 Modelled IHME
31 (27 - 35) 2001 Modelled IHME
31 (27 - 35) 2000 Modelled IHME
31 (28 - 35) 1999 Modelled IHME
32 (28 - 36) 1998 Modelled IHME
31 (28 - 35) 1997 Modelled IHME
31 (28 - 35) 1996 Modelled IHME
31 (28 - 35) 1995 Modelled IHME
32 (28 - 36) 1994 Modelled IHME
32 (28 - 36) 1993 Modelled IHME
32 (28 - 36) 1992 Modelled IHME
32 (28 - 36) 1991 Modelled IHME
32 (28 - 36) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (33 - 113) 2015 Survey/reported Alliance for Publi Health, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
5 (4.60 - 5.50) 2015 Survey/reported Barska G and Sazanov JA, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2002
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
1.3 (%)
2019
(1.14 - 1.47(%))
IHME
HCV (RNA/cAg+)
2.7 (%)
2019
(2.18 - 3.34(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
3,799
2019
(2,968 - 4,764)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4,298
2019
(3,416 - 5,344)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.29 (%)
2019, latest modelled
(0.23 - 0.35(%))
IHME

Prevalence PWID

HCV
53.90 (%)
2015, latest modelled
(49.20 - 58.70(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
49 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
61
2015
(33 - 113)
Alliance for Publi Health, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs

Partners